Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer (Q34290118)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer |
scientific article |
Statements
1 reference
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer (English)
1 reference
Amanda Kirane
1 reference
Jason E Toombs
1 reference
Katherine Ostapoff
1 reference
Juliet G Carbon
1 reference
Sara Zaknoen
1 reference
Jordan Braunfeld
1 reference
Roderich E Schwarz
1 reference
Francis J Burrows
1 reference
Rolf A Brekken
1 reference
24 July 2012
1 reference
1 reference
18
1 reference
18
1 reference
5031-5042
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference